Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced in March and April 2017.
Arsanis Inc. raised $45.5m in its Series D financing led by the Bill & Melinda Gates Foundation, which was...






